MediSys Corporation: MediSys Corporation's Medical Model Goes Mainstream On NBC's "The Today Show"
PALM BEACH GARDENS, FL--(Marketwire - February 24, 2009) - MediSys Corporation (
The segment can be viewed at the Today show's website. [ http://today.msnbc.msn.com/id/26184891/vp/29239374#29255695 ].
MediSys' CEO Joshua Konigsberg states, "It's really important for men in our society to understand the correlations between ED and other underlying diseases." Now that the mainstream media has announced these findings we hope that men will go to their doctor or a MaxLife Center for Men™ to get evaluated and treated. We have known and proven for over 6 years the direct correlation between ED and other serious life-threatening diseases in men such as heart disease. Our technology helps the doctor to find the exact underlying disease or diseases.
About MediSys
MediSys' proprietary disease identification and management system for men (The MaxLife Center for Men™) enables physicians to make the best decisions in terms of diagnosis and treatment for a large number of serious diseases prevalent in men. Working with nationally acclaimed medical doctors, the Management Team discovered that many serious and sometimes life-threatening diseases prevalent in men often share common underlying symptoms.
Disclaimer Regarding Forward-Looking Statements:
This announcement may contain certain forward-looking statements that are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated. Forward-looking statements speak only as of the date the statement was made. The Company assumes no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. If the Company does update any forward-looking statement, no inference should be drawn that the Company will make additional updates with respect to that statement or any other forward-looking statements.